First Trust International Equity Opportunities ETF (FPXI)

On our desk, sentiment around FPXI remains cautiously neutral with a mildly defensive slant across about 56% of recent commentary. While the 10-year alpha profile of 0.51 looks impressive on paper, you cannot ignore the Morningstar Very Aggressive risk score of 93. The fund takes on a standard deviation of 22.7% versus the category average of 16.9%, which punished holders severely during the 2021-2022 growth drawdown when it fell roughly 12 percentage points deeper than peers. If you are playing the 2026 IPO revival thesis, you have to stomach that concentration risk.

Looking at the portfolio composition from a risk-management lens, concentration is our primary headache here. Just the top two holdings alone—Advantest at 10.84% and CATL at 9.09%—make up roughly 20% of the entire fund. Combined with the IPOX International Index's explicit focus on recent non-US IPOs, spin-offs, and acquirers, you are inheriting a high-beta vehicle. Even though the portfolio P/E sits at a modest 19.71x relative to an 18.46% long-term earnings growth estimate, ongoing trade-policy deliberations and US tariff uncertainties through mid-2026 present clear headwinds for these export-heavy industrial and tech positions.

Watching the technicals on our trading floor, FPXI trades around $63.04 to $79.42 depending on real-time feeds, sitting comfortably about 4.79% above its 200-day moving average of $60.19 with a monthly RSI of 62.3. That points to a healthy structure rather than an overextended one, supported by a softer US dollar providing a natural currency tailwind for unhedged non-US equities. However, when evaluating the quantitative protocol for execution, analysts must weigh the short-term momentum against the 5-year Sharpe ratio of 0.02, which underperformed the category baseline of 0.05 during broader growth corrections.